MBS items 14206, 30062, 35501, 35503. Includes the 40% bulk billing loading introduced November 2025. Verified against MBS Book July 2026.
| Item | Description | Schedule fee | 85% benefit |
|---|---|---|---|
| 14206 | Hormonal implant (Implanon) insertion | $103.00 | $87.55 |
| 30062 | Etonogestrel subcutaneous implant removal | $107.90 | $91.75 |
| 35501 | LARC bulk billing loading — 40% of co-claimed LARC item fee NEW Nov 2025 | Derived | Derived |
| 35503 | IUD insertion (Mirena, Kyleena, copper) | $221.55 | $188.35 |
| 35506 | IUD removal under GA (retained/embedded device only) | $137.95 | $103.50 (75% — hospital item) |
Source: MBS Book July 2026. Items verified against TN.0.1 explanatory note.
Example — Implanon insertion bulk billed:
Item 14206: $103.00 → 35501 loading: $41.20 (40% of $103.00) → Total Medicare: $144.20
Example — Implanon removal bulk billed:
Item 30062: $107.90 → 35501 loading: $43.16 (40% of $107.90) → Total Medicare: $151.06
Routine IUD removal (no GA required): Bill under an appropriate attendance item (e.g. item 23, 36, 44). Item 35501 does not apply to standalone IUD removal without GA.
IUD removal under GA (retained or embedded device): Bill item 35506 ($137.95) + item 35501 loading if bulk billed. This is a hospital item.
Yes, if there is a genuinely separate clinical issue. If the patient also discusses something unrelated to the LARC procedure (e.g. blood pressure review, mental health, a new symptom), you can bill the consultation item alongside the procedure item.
No, if the visit is solely for the procedure. If the appointment is a pre-booked procedure with no separate clinical issue addressed, bill only the procedure item.
35501 loading and the consultation: If you do bill a consultation alongside a LARC item, the consultation must also be bulk billed for 35501 to apply. Document the separate clinical content clearly.
Australian guidelines recommend risk-based STI screening before IUD insertion, not routine testing of everyone. The rationale: uterine instrumentation disrupts the cervical epithelium, allowing vaginal bacteria to ascend — IUD insertion in the presence of untreated chlamydia or gonorrhoea increases PID risk.
Source: Australian STI Management Guidelines (sti.guidelines.org.au — PID section, updated 2024–25); RANZCOG. Always exercise clinical judgment based on the individual patient. This is general guidance — not a substitute for clinical assessment.